{"product_id":"quality-in-laboratory-hemostasis-and-thrombosis-isbn-9780470671191","title":"Quality in Laboratory Hemostasis and Thrombosis","description":"\u003cp\u003e\u003cb\u003eQuality in Laboratory Hemostasis and Thrombosis\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eSecond Edition\u003c\/p\u003e \u003cp\u003eEdited by\u003c\/p\u003e \u003cp\u003e\u003cb\u003eSteve Kitchen\u003c\/b\u003e, Clinical Scientist, Sheffield Haemophilia and Thrombosis Centre, Royal Hallamshire Hospital and Scientific Director, UK National External Quality Assessment Scheme (FQAS) for Blood Coagulation, Scientific Director, WHO and WFH International External Quality Assessment Programs for Blood Coagulation, Sheffield, UK\u003c\/p\u003e \u003cp\u003e\u003cb\u003eJohn D Olson\u003c\/b\u003e, Professor and Vice Chair for Clinical Affairs, Department of Pathology, University of Texas Health Sciences Centre, San Antonio, Texas, USA\u003c\/p\u003e \u003cp\u003e\u003cb\u003eF. Eric Preston\u003c\/b\u003e, Emeritus Professsor of Haematology, University of Sheffield and Director, WHO and WFH International External Quality Assessment Programs for Blood Coagulations, Sheffield, UK\u003c\/p\u003e \u003cp\u003eThe hemostasis laboratory has a vital role in the diagnosis and management of patients with familial and acquired hemorrhagic and thrombotic disorders. Rapid changes in the number and complexity of tests in this discipline have presented challenges for laboratories, as they develop quality programs for the oversight of this testing.\u003c\/p\u003e \u003cp\u003e\u003ci\u003eQuality in Laboratory Hemostasis and Thrombosis\u003c\/i\u003e has been completely revised and updated to reflect the changing process of managing quality. The second edition provides information on all aspects of testing, from pre-analytic to analytic and result reporting, in addition to external quality assurance. Chapters throughout the book include the development of global guidelines for methods, as well as the preparation of international standard plasmas and reagents.\u003c\/p\u003e \u003cp\u003eDesigned to capture the elements of quality at all levels of the practice of laboratory hemostasis and thrombosis, this book will guide the reader through the development of a quality program to support all activities in the hemostasis laboratory, both simple and complex.\u003c\/p\u003e \u003cp\u003e\u003cb\u003eTitles of related interest\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eLee: Textbook of Hemophilia, 2e (2010)\u003cbr\u003e ISBN 9781405169141\u003c\/p\u003e \u003cp\u003eFederici: Von Willebrand Disease: Basic and Clinical Aspects, 1e (2011)\u003cbr\u003e ISBN  9781405195126\u003c\/p\u003e \u003cp\u003eMa: Hemophilia and Hemostasis: A Case Based Approach to Management, 2e (2012)\u003cbr\u003e ISBN 9780470659762\u003c\/p\u003e \u003cp\u003e \u003c\/p\u003e \u003cp\u003eContributors vii\u003c\/p\u003e \u003cp\u003eForeword x\u003c\/p\u003e \u003cp\u003ePreface xii\u003cbr\u003e \u003ci\u003eSteve Kitchen John D. Olson \u0026amp; F. Eric Preston\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePart 1: General Quality Program\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e1 General quality planning in the hemostasis laboratory 3\u003cbr\u003e \u003ci\u003eJohn D. Olson\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e2 Hemostasis test validation performance and reference intervals: international recommendations and guidelines 12\u003cbr\u003e \u003ci\u003eRichardA.Marlar\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e3 Causes of errors in medical laboratories 22\u003cbr\u003e \u003ci\u003eGiuseppe Lippi \u0026amp; Emmanuel J. Favaloro\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e4 International standards in hemostasis 32\u003cbr\u003e \u003ci\u003eTrevor W. Barrowcliffe \u0026amp; Anthony R. Hubbard\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e5 Sample integrity and preanalytical variables 45\u003cbr\u003e \u003ci\u003eDorothy (Adcock) Funk\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e6 Internal quality control in the hemostasis laboratory 57\u003cbr\u003e \u003ci\u003eSteve Kitchen F. Eric Preston \u0026amp; John D. Olson\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e7 External quality assessment in hemostasis: its importance and significance 65\u003cbr\u003e \u003ci\u003eF. Eric Preston Steve Kitchen \u0026amp; Alok Srivastava\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e8 The unique challenges of hemostatic testing in children 77\u003cbr\u003e \u003ci\u003eM. Patricia Massicotte Mary E. Bauman Vanessa Chan \u0026amp; Anthony K.C. Chan\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePart 2: Quality in Coagulation Testing\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e9 Initial evaluation of hemostasis: reagent and method selection 95\u003cbr\u003e \u003ci\u003eWayne L. Chandler\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e10 Assay of factor VIII and other clotting factors 105\u003cbr\u003e \u003ci\u003eSteve Kitchen \u0026amp; F. Eric Preston\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e11 Application of molecular genetics to the investigation of inherited bleeding disorders 115\u003cbr\u003e \u003ci\u003eStefan Lethagen Morten Dunø \u0026amp; Lars Bo Nielsen\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e12 Detecting and quantifying acquired functional inhibitors in hemostasis 124\u003cbr\u003e \u003ci\u003eBert Verbruggen Myriam Dardikh \u0026amp; Britta Laros-van Gorkom\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e13 Standardization of d-dimer testing 136\u003cbr\u003e \u003ci\u003eGuido Reber \u0026amp; Philippe de Moerloose\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e14 Point-of-care testing in hemostasis 147\u003cbr\u003e \u003ci\u003eChris Gardiner Dianne Kitchen Samuel Machin \u0026amp; Ian Mackie\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePart 3: Quality in Testing for Platelet Function and von Willebrand Disease\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e15 Diagnostic assessment of platelet function 159\u003cbr\u003e \u003ci\u003ePaquita Nurden Alan Nurden \u0026amp; Martine Jandrot-Perrus\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e16 Laboratory evaluation of heparin-induced thrombocytopenia 174\u003cbr\u003e \u003ci\u003eTheodore (Ted) E. Warkentin \u0026amp; Jane C. Moore\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e17 Laboratory evaluation of von Willebrand disease: phenotypic analysis 192\u003cbr\u003e \u003ci\u003eEmmanuel J. Favaloro\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e18 Laboratory analysis of von Willebrand disease: molecular analysis 204\u003cbr\u003e \u003ci\u003eAnne C. Goodeve \u0026amp; Ian R. Peake\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePart 4: Quality in Thrombophilia Testing and Monitoring Anticoagulation\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e19 Quality issues in heritable thrombophilia testing 219\u003cbr\u003e \u003ci\u003eIsobel D. Walker \u0026amp; Ian Jennings\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e20 Evaluation of antiphospholipid antibodies 233\u003cbr\u003e \u003ci\u003eMichael Greaves\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e21 Monitoring heparin therapy 244\u003cbr\u003e \u003ci\u003eMarilyn Johnston\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e22 Monitoring oral anticoagulant therapy with vitamin K antagonists 253\u003cbr\u003e \u003ci\u003eArmando Tripodi\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e23 Monitoring new anticoagulants 264\u003cbr\u003e \u003ci\u003eElaine Gray \u0026amp; Trevor W. Barrowcliffe\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eIndex 273\u003c\/p\u003e  \u003cp\u003e\u003cstrong\u003eDr Steve Kitchen\u003c\/strong\u003e, Clinical Scientist, Sheffield Hemophila and Thromobosis Centre, Royal Hallamshire Hospital and Scientific Director, UK National External Quality Assessment Scheme (FQAS) for Blood Coagulation, Scientific Director, WHO and WFH International External Quality Assessment Programs for Blood Coagulation, Sheffield, UK. \u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eJohn D Olson\u003c\/strong\u003e, Professor and Vice Chair for Clinical Affairs, Department of Pathology, University of Texas Health Sciences Centre, San Antonio, Texas, USA. \u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eF. Eric Preston\u003c\/strong\u003e, Emeritus Professsor of Hematology, University of Sheffield and Director, WHO and WFH International External Quality Assessment Programs for Blood Coagulations, Sheffield, UK.   \u003c\/p\u003e\u003cp\u003e\u003cb\u003eQuality in Laboratory Hemostasis and Thrombosis\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eSecond Edition\u003c\/p\u003e \u003cp\u003eEdited by\u003c\/p\u003e \u003cp\u003e\u003cb\u003eSteve Kitchen\u003c\/b\u003e, Clinical Scientist, Sheffield Haemophilia and Thrombosis Centre, Royal Hallamshire Hospital and Scientific Director, UK National External Quality Assessment Scheme (FQAS) for Blood Coagulation, Scientific Director, WHO and WFH International External Quality Assessment Programs for Blood Coagulation, Sheffield, UK\u003c\/p\u003e \u003cp\u003e\u003cb\u003eJohn D Olson\u003c\/b\u003e, Professor and Vice Chair for Clinical Affairs, Department of Pathology, University of Texas Health Sciences Centre, San Antonio, Texas, USA\u003c\/p\u003e \u003cp\u003e\u003cb\u003eF. Eric Preston\u003c\/b\u003e, Emeritus Professsor of Haematology, University of Sheffield and Director, WHO and WFH International External Quality Assessment Programs for Blood Coagulations, Sheffield, UK\u003c\/p\u003e \u003cp\u003eThe hemostasis laboratory has a vital role in the diagnosis and management of patients with familial and acquired hemorrhagic and thrombotic disorders. Rapid changes in the number and complexity of tests in this discipline have presented challenges for laboratories, as they develop quality programs for the oversight of this testing.\u003c\/p\u003e \u003cp\u003e\u003ci\u003eQuality in Laboratory Hemostasis and Thrombosis\u003c\/i\u003e has been completely revised and updated to reflect the changing process of managing quality. The second edition provides information on all aspects of testing, from pre-analytic to analytic and result reporting, in addition to external quality assurance. Chapters throughout the book include the development of global guidelines for methods, as well as the preparation of international standard plasmas and reagents.\u003c\/p\u003e \u003cp\u003eDesigned to capture the elements of quality at all levels of the practice of laboratory hemostasis and thrombosis, this book will guide the reader through the development of a quality program to support all activities in the hemostasis laboratory, both simple and complex.\u003c\/p\u003e \u003cp\u003e\u003cb\u003eTitles of related interest\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eLee: Textbook of Hemophilia, 2e (2010)\u003cbr\u003e ISBN 9781405169141\u003c\/p\u003e \u003cp\u003eFederici: Von Willebrand Disease: Basic and Clinical Aspects, 1e (2011)\u003cbr\u003e ISBN  9781405195126\u003c\/p\u003e \u003cp\u003eMa: Hemophilia and Hemostasis: A Case Based Approach to Management, 2e (2012)\u003cbr\u003e ISBN 9780470659762\u003c\/p\u003e \u003cp\u003e \u003c\/p\u003e","brand":"Wiley-Blackwell","offers":[{"title":"Default Title","offer_id":47989894152421,"sku":"NP9780470671191","price":154.95,"currency_code":"USD","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1842\/7735\/files\/9780470671191.jpg?v=1761785823","url":"https:\/\/k12savings.com\/products\/quality-in-laboratory-hemostasis-and-thrombosis-isbn-9780470671191","provider":"K12savings","version":"1.0","type":"link"}